![](http://home.ecri.org/cdn/shop/files/Blog-placeholder-image.jpg?v=1715887074)
News brief covers ISMP’s alert warning pharmacists about potential error risks with Paxlovid, a COVID-antivral regimen, highlighting that patients with moderate renal impairment should receive a dose reduction.
For the full text, visit Becker’s Hospital Review online.